Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
220.8 CHF | +0.34% | -2.65% | -9.98% |
Apr. 17 | Roche’s Multiple Sclerosis Injection Controls Relapses, Brain Lesions in Late-stage Trial | MT |
Apr. 17 | Roche: positive phase III results in MS | CF |
Sales 2024 * | 59.84B 65.79B | Sales 2025 * | 63.41B 69.71B | Capitalization | 177B 195B |
---|---|---|---|---|---|
Net income 2024 * | 13.38B 14.71B | Net income 2025 * | 14.66B 16.11B | EV / Sales 2024 * | 3.19 x |
Net Debt 2024 * | 13.47B 14.81B | Net Debt 2025 * | 7.31B 8.03B | EV / Sales 2025 * | 2.91 x |
P/E ratio 2024 * |
13.2
x | P/E ratio 2025 * |
11.9
x | Employees | 103,605 |
Yield 2024 * |
4.36% | Yield 2025 * |
4.53% | Free-Float | 88.91% |
Latest transcript on Roche Holding AG
1 day | -0.41% | ||
1 week | -1.92% | ||
Current month | -4.18% | ||
1 month | -4.64% | ||
3 months | -10.98% | ||
6 months | -12.83% | ||
Current year | -9.98% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 02-12-31 | |
Severin Schwan
CHM | Chairman | 57 | 07-12-31 |
Alan Hippe
DFI | Director of Finance/CFO | 57 | 11-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bernard Poussot
BRD | Director/Board Member | 72 | 15-03-02 |
Director/Board Member | 59 | - | |
Director/Board Member | 65 | 95-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
9.03% | 121 M€ | -.--% | - | |
8.46% | 18 M€ | +2.91% | - | |
4.67% | 2 M€ | -.--% | ||
2.85% | 6 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 220.3 | +0.09% | 57 530 |
24-04-17 | 220.1 | -0.63% | 1,102,421 |
24-04-16 | 221.5 | -1.60% | 1,195,512 |
24-04-15 | 225.1 | +0.04% | 761,091 |
24-04-12 | 225 | -0.49% | 1,292,148 |
Delayed Quote Swiss Exchange, April 17, 2024 at 11:31 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.98% | 194B | |
+28.79% | 676B | |
+24.81% | 554B | |
-7.64% | 349B | |
+15.00% | 318B | |
+5.99% | 291B | |
+2.47% | 210B | |
-0.02% | 204B | |
-11.71% | 144B | |
-8.32% | 142B |
- Stock Market
- Equities
- ROG Stock